JP7497484B1 - Composition - Google Patents
Composition Download PDFInfo
- Publication number
- JP7497484B1 JP7497484B1 JP2023056031A JP2023056031A JP7497484B1 JP 7497484 B1 JP7497484 B1 JP 7497484B1 JP 2023056031 A JP2023056031 A JP 2023056031A JP 2023056031 A JP2023056031 A JP 2023056031A JP 7497484 B1 JP7497484 B1 JP 7497484B1
- Authority
- JP
- Japan
- Prior art keywords
- compound
- carboxylic acid
- composition
- acid
- amine compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 112
- -1 amine compound Chemical class 0.000 claims abstract description 167
- 239000003504 photosensitizing agent Substances 0.000 claims abstract description 40
- 150000003839 salts Chemical class 0.000 claims abstract description 23
- 238000013268 sustained release Methods 0.000 claims abstract description 21
- 239000012730 sustained-release form Substances 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims description 42
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 33
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 28
- 239000000194 fatty acid Substances 0.000 claims description 28
- 229930195729 fatty acid Natural products 0.000 claims description 28
- 150000004665 fatty acids Chemical class 0.000 claims description 28
- 125000003277 amino group Chemical group 0.000 claims description 25
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- HAUGRYOERYOXHX-UHFFFAOYSA-N Alloxazine Chemical compound C1=CC=C2N=C(C(=O)NC(=O)N3)C3=NC2=C1 HAUGRYOERYOXHX-UHFFFAOYSA-N 0.000 claims description 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 16
- 235000013985 cinnamic acid Nutrition 0.000 claims description 13
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 13
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 10
- 229930016911 cinnamic acid Natural products 0.000 claims description 10
- 230000000843 anti-fungal effect Effects 0.000 claims description 9
- 239000003349 gelling agent Substances 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 description 21
- 229920002873 Polyethylenimine Polymers 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 230000001699 photocatalysis Effects 0.000 description 12
- 125000001424 substituent group Chemical group 0.000 description 12
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 11
- 229960002477 riboflavin Drugs 0.000 description 11
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 150000002430 hydrocarbons Chemical group 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 235000019192 riboflavin Nutrition 0.000 description 10
- 239000002151 riboflavin Substances 0.000 description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 9
- ZJTJUVIJVLLGSP-UHFFFAOYSA-N lumichrome Chemical compound N1C(=O)NC(=O)C2=C1N=C1C=C(C)C(C)=CC1=N2 ZJTJUVIJVLLGSP-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 150000004804 polysaccharides Chemical class 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 7
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 7
- 125000005843 halogen group Chemical group 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 229960002442 glucosamine Drugs 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000003021 water soluble solvent Substances 0.000 description 6
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 229940121375 antifungal agent Drugs 0.000 description 5
- 229950000688 phenothiazine Drugs 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 4
- 239000003905 agrochemical Substances 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 4
- 150000004056 anthraquinones Chemical class 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 4
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 230000008719 thickening Effects 0.000 description 4
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 3
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 3
- 235000001785 ferulic acid Nutrition 0.000 description 3
- 229940114124 ferulic acid Drugs 0.000 description 3
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 3
- 150000002337 glycosamines Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 229960002446 octanoic acid Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 3
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 3
- 239000012808 vapor phase Substances 0.000 description 3
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 2
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 2
- YPIFGDQKSSMYHQ-UHFFFAOYSA-N 7,7-dimethyloctanoic acid Chemical compound CC(C)(C)CCCCCC(O)=O YPIFGDQKSSMYHQ-UHFFFAOYSA-N 0.000 description 2
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005643 Pelargonic acid Substances 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- OHSHFZJLPYLRIP-BMZHGHOISA-M Riboflavin sodium phosphate Chemical compound [Na+].OP(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O OHSHFZJLPYLRIP-BMZHGHOISA-M 0.000 description 2
- NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 2
- 229960005054 acepromazine Drugs 0.000 description 2
- PWAXUOGZOSVGBO-UHFFFAOYSA-N adipoyl chloride Chemical compound ClC(=O)CCCCC(Cl)=O PWAXUOGZOSVGBO-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 2
- 229960001076 chlorpromazine Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000007771 core particle Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 229960002887 deanol Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012972 dimethylethanolamine Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- REXANTGEEZXBSJ-UHFFFAOYSA-L disodium;4',5'-dibromo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC=C([O-])C(Br)=C1OC1=C(Br)C([O-])=CC=C21 REXANTGEEZXBSJ-UHFFFAOYSA-L 0.000 description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 2
- 229940043264 dodecyl sulfate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- ZBQZBWKNGDEDOA-UHFFFAOYSA-N eosin B Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC([N+]([O-])=O)=C(O)C(Br)=C1OC1=C2C=C([N+]([O-])=O)C(O)=C1Br ZBQZBWKNGDEDOA-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- 238000007146 photocatalysis Methods 0.000 description 2
- 239000011941 photocatalyst Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- 229950001574 riboflavin phosphate Drugs 0.000 description 2
- 150000003287 riboflavins Chemical class 0.000 description 2
- 229930187593 rose bengal Natural products 0.000 description 2
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 description 2
- 229940081623 rose bengal Drugs 0.000 description 2
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- DGYYJSHANXEPSK-UHFFFAOYSA-N 1-methyl-10h-phenothiazine Chemical compound S1C2=CC=CC=C2NC2=C1C=CC=C2C DGYYJSHANXEPSK-UHFFFAOYSA-N 0.000 description 1
- LHDDFSJNFGMGEX-UHFFFAOYSA-N 11-methyldodecyl hydrogen sulfate Chemical compound CC(C)CCCCCCCCCCOS(O)(=O)=O LHDDFSJNFGMGEX-UHFFFAOYSA-N 0.000 description 1
- MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 1
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
- UAZLASMTBCLJKO-UHFFFAOYSA-N 2-decylbenzenesulfonic acid Chemical compound CCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O UAZLASMTBCLJKO-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- PVXSFEGIHWMAOD-UHFFFAOYSA-N 2-tridecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O PVXSFEGIHWMAOD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- CDSULTPOCMWJCM-UHFFFAOYSA-N 4h-chromene-2,3-dione Chemical compound C1=CC=C2OC(=O)C(=O)CC2=C1 CDSULTPOCMWJCM-UHFFFAOYSA-N 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N 9,10-anthraquinone Chemical group C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- PTKWYSNDTXDBIZ-UHFFFAOYSA-N 9,10-dioxoanthracene-1,2-disulfonic acid Chemical compound C1=CC=C2C(=O)C3=C(S(O)(=O)=O)C(S(=O)(=O)O)=CC=C3C(=O)C2=C1 PTKWYSNDTXDBIZ-UHFFFAOYSA-N 0.000 description 1
- POPBYCBXVLHSKO-UHFFFAOYSA-N 9,10-dioxoanthracene-1-carboxylic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2C(=O)O POPBYCBXVLHSKO-UHFFFAOYSA-N 0.000 description 1
- JAJIPIAHCFBEPI-UHFFFAOYSA-N 9,10-dioxoanthracene-1-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2S(=O)(=O)O JAJIPIAHCFBEPI-UHFFFAOYSA-N 0.000 description 1
- MMNWSHJJPDXKCH-UHFFFAOYSA-N 9,10-dioxoanthracene-2-sulfonic acid Chemical compound C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 MMNWSHJJPDXKCH-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GDALETGZDYOOGB-UHFFFAOYSA-N Acridone Natural products C1=C(O)C=C2N(C)C3=CC=CC=C3C(=O)C2=C1O GDALETGZDYOOGB-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 150000004265 D-glucosamines Chemical class 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000426 Microplastic Polymers 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- VKVDYPHLGLIXAG-VWPQPMDRSA-N [(2r,3s,4s)-2,3,4-triacetyloxy-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)pentyl] acetate Chemical compound CC(=O)OC[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](OC(C)=O)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O VKVDYPHLGLIXAG-VWPQPMDRSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- OOGYVVYCCYJADG-UHFFFAOYSA-N acridine-1-carboxylic acid Chemical compound C1=CC=C2C=C3C(C(=O)O)=CC=CC3=NC2=C1 OOGYVVYCCYJADG-UHFFFAOYSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229930006711 bornane-2,3-dione Natural products 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000006787 czapek-dox agar Substances 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000004495 emulsifiable concentrate Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- IXZISFNWUWKBOM-ARQDHWQXSA-N fructosamine Chemical compound NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O IXZISFNWUWKBOM-ARQDHWQXSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 238000003988 headspace gas chromatography Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- SSILHZFTFWOUJR-UHFFFAOYSA-N hexadecane-1-sulfonic acid Chemical compound CCCCCCCCCCCCCCCCS(O)(=O)=O SSILHZFTFWOUJR-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WLGDAKIJYPIYLR-UHFFFAOYSA-N octane-1-sulfonic acid Chemical compound CCCCCCCCS(O)(=O)=O WLGDAKIJYPIYLR-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- UEHGPSGGFKLPTD-KVTDHHQDSA-N perosamine Chemical compound C[C@@H](O)[C@@H](N)[C@H](O)[C@H](O)C=O UEHGPSGGFKLPTD-KVTDHHQDSA-N 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000013032 photocatalytic reaction Methods 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- WZAPMUSQALINQD-UHFFFAOYSA-M potassium;ethenyl sulfate Chemical compound [K+].[O-]S(=O)(=O)OC=C WZAPMUSQALINQD-UHFFFAOYSA-M 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-M sodium 2-anthraquinonesulfonate Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)[O-])=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-N trans-cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
【課題】機能性成分の徐放性を備える組成物を提供すること。【解決手段】光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)とを含有し、前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成している、組成物。【選択図】図1[Problem] To provide a composition having sustained release of a functional component. [Solution] The composition contains a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C), and at least a portion of the amine compound (B) and the carboxylic acid compound (C) form a salt. [Selected Figure] Figure 1
Description
本発明は、組成物、詳しくは特定物質を徐放する徐放性組成物に関する。 The present invention relates to a composition, specifically a sustained release composition that sustains the release of a specific substance.
医薬品、香料、農薬、肥料等の機能性成分の効果を持続させるために、これらの機能性成分を徐々に放出する徐放性材料が検討されている。
当該徐放性材料としては、マイクロカプセルや、多孔質基材を有するもの等が挙げられる。
例えば特許文献1には、ポリマーと機能性成分を含むコア粒子と、当該コア粒子を覆う微細化セルロースを有する特定の徐放性複合粒子が記載されている。
特許文献2には、油相と、特定の感光性ポリマーと、光触媒とを含むコアと、界面重合により形成される特定のシェルを含むマイクロカプセルが記載されており、光照射により油相を放出することが記載されている。
また特許文献3には、特定の金属酸化物多孔質粒子と、特定の徐放性物質と、を含む徐放性材料が開示されている。
2. Description of the Related Art In order to sustain the effects of functional ingredients such as medicines, fragrances, agricultural chemicals, and fertilizers, sustained release materials that gradually release these functional ingredients have been investigated.
The sustained release material may be a microcapsule or a material having a porous substrate.
For example, Patent Document 1 describes specific sustained-release composite particles having core particles containing a polymer and a functional component, and micronized cellulose covering the core particles.
Furthermore, Patent Document 3 discloses a sustained release material containing specific metal oxide porous particles and a specific sustained release substance.
また、特定の化合物を放出する化合物として、ケージド化合物が知られている。ケージド化合物は、生理活性物質等を光で脱保護可能な保護基で修飾し、不活性化状態にした化合物である。ケージド化合物は、通常、分子内に光吸収性部位を有し、光を照射することで前記化合物を放出する。
特許文献4には、短時間の光照射で化合物を放出する方法として、特定のケージド化合物に対し、光増感剤の存在下に光照射する方法が開示されている。
In addition, caged compounds are known as compounds that release specific compounds. Caged compounds are compounds in which a biologically active substance or the like is modified with a protecting group that can be deprotected by light, rendering it inactive. Caged compounds usually have a light-absorbing site in the molecule, and release the compound by irradiation with light.
Patent Document 4 discloses a method for releasing a compound by short-term light irradiation, in which a specific caged compound is irradiated with light in the presence of a photosensitizer.
特許文献1~3の徐放性材料は、ポリマー及びマイクロカプセルの合成や、多孔質粒子の製造が必須であり、より生産性に優れた徐放性材料が求められている。また、マイクロカプセルのポリマー(マイクロプラスチック)や多孔質粒子は使用後に残留し環境に影響し得る問題があった。 The sustained-release materials in Patent Documents 1 to 3 require the synthesis of polymers and microcapsules and the production of porous particles, and sustained-release materials with superior productivity are in demand. In addition, there is a problem in that the polymers (microplastics) of the microcapsules and the porous particles remain after use, which can have an impact on the environment.
本発明は、機能性成分の徐放性を備える組成物の提供を目的とする。 The present invention aims to provide a composition that provides sustained release of a functional ingredient.
本発明は、下記[1]~[14]の構成を有する組成物を提供する。
[1] 光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)とを含有し、
前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成している、組成物。
[2] 前記光増感剤(A)が、イソアロキサジン、アロキサジン、フェノチアジン、フルオレセイン、アントラキノン及びアクリジンより選択される骨格を有する化合物を含む、上記[1]に記載の組成物。
[3] 前記アミン化合物(B)が、アミノ基のα水素を有する化合物を含む、上記[1]又は[2]に記載の組成物。
[4] 前記アミン化合物(B)が、アミノ基と、親水性基とを有する化合物を含む、上記[1]~[3]のいずれかに記載の組成物。
[5] 前記親水性基が、アミノ基、グアニジノ基、カルボキシ基、及びヒドロキシ基より選択される1種以上を含む、上記[4]に記載の組成物。
[6] 前記アミン化合物(B)が、アルカノールアミン、アミノ酸、及びアミノ糖より選択される1種以上を含む、上記[1]~[5]のいずれかに記載の組成物。
[7] 前記カルボン酸化合物(C)が、脂肪酸及びケイ皮酸類より選択される1種以上を含む、上記[1]~[6]のいずれかに記載の組成物。
[8] 前記アミン化合物(B)が有するアミノ基と前記カルボン酸化合物(C)が有するカルボキシ基とのモル比(アミノ基/カルボキシ基)が1.0以上である、上記[1]~[7]のいずれかに記載の組成物。
[9] 更に、ゲル化剤を含有する、上記[1]~[8]のいずれかに記載の組成物。
[10] 前記カルボン酸化合物(C)を徐放する、上記[1]~[9]のいずれかに記載の組成物。
[11] 光照射により、前記カルボン酸化合物(C)を徐放する、上記[1]~[10]のいずれかに記載の組成物。
[12] 前記カルボン酸化合物(C)が、炭素数3~15の脂肪酸、又はケイ皮酸類を含み、コケ除去性を有する、上記[1]~[11]のいずれかに記載の組成物。
[13] 前記カルボン酸化合物(C)が、炭素数3~15の脂肪酸を含み、防カビ性を有する、上記[1]~[12]のいずれかに記載の組成物。
[14] 光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)とを含有し、
前記光増感剤(A)が、イソアロキサジン及びアロキサジンより選択される骨格を有する化合物を含み、
前記アミン化合物(B)が、アミノ基のα水素を有する化合物を含み、
前記カルボン酸化合物(C)が、脂肪酸を含み、
前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成しており、
光照射により、前記カルボン酸化合物(C)を徐放する、徐放性組成物。
The present invention provides a composition having the following configurations [1] to [14].
[1] A composition comprising a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C),
A composition in which the amine compound (B) and the carboxylic acid compound (C) at least partially form a salt.
[2] The composition according to the above [1], wherein the photosensitizer (A) includes a compound having a skeleton selected from isoalloxazine, alloxazine, phenothiazine, fluorescein, anthraquinone, and acridine.
[3] The composition according to the above [1] or [2], wherein the amine compound (B) includes a compound having an α-hydrogen of an amino group.
[4] The composition according to any one of the above [1] to [3], wherein the amine compound (B) includes a compound having an amino group and a hydrophilic group.
[5] The composition according to the above [4], wherein the hydrophilic group includes one or more selected from an amino group, a guanidino group, a carboxy group, and a hydroxy group.
[6] The composition according to any one of the above [1] to [5], wherein the amine compound (B) comprises one or more selected from the group consisting of alkanolamines, amino acids, and amino sugars.
[7] The composition according to any one of the above [1] to [6], wherein the carboxylic acid compound (C) includes one or more selected from fatty acids and cinnamic acids.
[8] The composition according to any one of the above [1] to [7], wherein a molar ratio of an amino group in the amine compound (B) to a carboxy group in the carboxylic acid compound (C) (amino group/carboxy group) is 1.0 or more.
[9] The composition according to any one of the above [1] to [8], further comprising a gelling agent.
[10] The composition according to any one of the above [1] to [9], which sustains release of the carboxylic acid compound (C).
[11] The composition according to any one of the above [1] to [10], which sustains release of the carboxylic acid compound (C) by light irradiation.
[12] The composition according to any one of the above [1] to [11], wherein the carboxylic acid compound (C) contains a fatty acid having 3 to 15 carbon atoms or a cinnamic acid, and has moss-removing properties.
[13] The composition according to any one of the above [1] to [12], wherein the carboxylic acid compound (C) contains a fatty acid having 3 to 15 carbon atoms and has antifungal properties.
[14] A composition comprising a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C),
the photosensitizer (A) contains a compound having a skeleton selected from isoalloxazine and alloxazine,
the amine compound (B) comprises a compound having an α hydrogen atom of an amino group,
The carboxylic acid compound (C) contains a fatty acid,
the amine compound (B) and the carboxylic acid compound (C) at least partially form a salt;
A sustained release composition which sustains the release of the carboxylic acid compound (C) by irradiation with light.
本発明により、機能性成分の徐放性を備える組成物が提供される。 The present invention provides a composition that provides sustained release of a functional ingredient.
以下、本発明に係る組成物について説明する。
なお本発明において「機能性成分」とは、放出されることにより有用な効果を発揮し得る成分をいう。
数値範囲を示す「~」は、特に断りのない限りその下限値及び上限値を含むものとする。
The composition according to the present invention will now be described.
In the present invention, the term "functional ingredient" refers to an ingredient that can exert a useful effect when released.
The term "to" indicating a range of numerical values includes the lower and upper limits, unless otherwise specified.
[組成物]
本組成物は、光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)とを含有し、前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成している。
本組成物は、上記の構成により、機能性成分としてカルボン酸化合物を徐放する組成物となる。本組成物中で、アミン化合物(B)と前記カルボン酸化合物(C)は塩を形成(中和)しており、光を照射すると、光増感剤(A)の作用により、アミン化合物(B)が分解すると推定される。その結果、カルボン酸化合物(C)は徐々に放出される。本組成物においてカルボン酸化合物(C)の徐放は光応答性を有するため、光の照射によりカルボン酸化合物(C)の放出量をコントロールすることも可能である。また本組成物は後述の方法により容易に調製でき、生産性にも優れている。
[Composition]
The composition contains a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C), and at least a portion of the amine compound (B) and the carboxylic acid compound (C) form a salt.
The composition has the above-mentioned constitution, and is a composition that slowly releases a carboxylic acid compound as a functional component. In the composition, the amine compound (B) and the carboxylic acid compound (C) form a salt (neutralization), and it is presumed that when light is irradiated, the amine compound (B) is decomposed by the action of the photosensitizer (A). As a result, the carboxylic acid compound (C) is gradually released. In the composition, the sustained release of the carboxylic acid compound (C) is photoresponsive, so it is also possible to control the amount of the carboxylic acid compound (C) released by irradiation with light. In addition, the composition can be easily prepared by the method described below, and is also excellent in productivity.
本組成物は、少なくとも光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)とを含有するものであり、本発明の効果を奏する範囲で更に他の成分を含有してもよいものである。以下、本組成物に含まれ得る各成分について説明する。 This composition contains at least a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C), and may further contain other components within the scope of the effects of the present invention. Each component that may be contained in this composition is described below.
<光増感剤(A)>
光増感剤(A)は、光触媒反応によりアミン化合物(B)を分解し得るものであればよく、公知の光増感剤の中から適宜選択して用いることができる。
光増感剤(A)としては、例えば、ナフタレン、アントラセン、フェナントレン、ピレン、ペリレン、ベンゾフェノン、フルオレン、ナフトキノン、アントラキノン、キサンテン、チオキサンテン、キサントン、イソアロキサジン、アロキサジン、フェノキサジン、フルオレセイン、フロキシン、チオキサントン、クマリン、ケトクマリン、シアニン、メロシアニン、オキソノール、ベンゾチアゾール、アクリジン、チアジン、オキサジン、インドリン、アズレン、アズレニウム、ポルフィリン、トリアリールメタン、フタロシアニン、フェノチアジン、スピロピラン、スピロオキサジン等の骨格を有する化合物;アクリドン、カルコン、ジベンザルアセトンなどの不飽和ケトン類;ベンジル、カンファーキノン等の1,2-ジケトン類;アゾ化合物、有機金属錯体などが挙げられる。光増感剤(A)は1種類を単独で、又は2種類以上を組み合わせて用いることができる。
上記各種骨格を有する化合物は、骨格を構成する炭素原子、窒素原子などが、置換基を有していてもよい。当該置換基としては、ハロゲン原子、水酸基;カルボキシ基、スルホ基等の酸性基;アミノ基、有機基などが挙げられ、酸性基及びアミノ基は塩形成していてもよく、有機基は更に置換基を有していてもよい。
光増感剤(A)は、アニオン性、カチオン性、中性のいずれであってもよいが、アミン化合物(B)との反応性の点から、中でも、アニオン性又は中性が好ましい。
<Photosensitizer (A)>
The photosensitizer (A) may be any one capable of decomposing the amine compound (B) by a photocatalytic reaction, and may be appropriately selected from known photosensitizers.
Examples of the photosensitizer (A) include compounds having a skeleton such as naphthalene, anthracene, phenanthrene, pyrene, perylene, benzophenone, fluorene, naphthoquinone, anthraquinone, xanthene, thioxanthene, xanthone, isoalloxazine, alloxazine, phenoxazine, fluorescein, phloxine, thioxanthone, coumarin, ketocoumarin, cyanine, merocyanine, oxonol, benzothiazole, acridine, thiazine, oxazine, indoline, azulene, azulenium, porphyrin, triarylmethane, phthalocyanine, phenothiazine, spiropyran, and spirooxazine; unsaturated ketones such as acridone, chalcone, and dibenzalacetone; 1,2-diketones such as benzyl and camphorquinone; azo compounds, and organometallic complexes. The photosensitizer (A) can be used alone or in combination of two or more kinds.
In the compounds having the above various skeletons, the carbon atoms and nitrogen atoms constituting the skeleton may have a substituent. Examples of the substituent include a halogen atom, a hydroxyl group, an acidic group such as a carboxy group or a sulfo group, an amino group, and an organic group. The acidic group and the amino group may form a salt, and the organic group may further have a substituent.
The photosensitizer (A) may be anionic, cationic or neutral, but is preferably anionic or neutral in terms of reactivity with the amine compound (B).
光増感剤(A)は、優れた光触媒作用が得られ、入手が容易な点から、三環系縮合環(Tricyclic)を有するものが好ましい。三環系縮合環としては、例えば、アントラセン、フェナントレン、フルオレン、アントラキノン、キサンテン、チオキサンテン、キサントン、イソアロキサジン、アロキサジン、フェノキサジン、フルオレセイン、チオキサントン、アクリジン、フェノチアジンなどの骨格を有する化合物が挙げられ、中でも、イソアロキサジン、アロキサジン、フェノチアジン、フルオレセイン、アントラキノン及びアクリジンより選択される骨格を有する化合物が好ましく、更に、可視光(例えば波長400~600nm)による光触媒性能の点からイソアロキサジン骨格又はアロキサジン骨格を有する化合物がより好ましい。
フェノチアジン骨格を有する化合物の具体例としては、ペルフェアジン、クロルプロマジン、アセプロマジン、フェノチアジン、メチルフェノチアジン、メチレンブルーなどが挙げられ、組成物の徐放性の点から、ペルフェアジン、クロルプロマジン又はアセプロマジンが好ましい。
フルオレセイン骨格を有する化合物の具体例としては、フルオレセイン、フロキシン、ジブロモフルオレセイン、エオシンY、エオシンB、ローダミンB、ローダミン6G、ローズベンガルなどが挙げられ、組成物の徐放性の点から、フルオレセイン、フロキシン、ジブロモフルオレセイン、エオシンY、エオシンB、又はローズベンガルが好ましい。
アントラキノン骨格を有する化合物の具体例としては、アントラキノンスルホン酸、アントラキノジスルホン酸、アントラキノンカルボン酸、2-アントラキノンスルホン酸、及びこれらのアルカリ金属塩などが挙げられる。
アクリジン骨格を有する化合物の具体例としては、アクリジンオレンジ、アクリジンカルボン酸などが挙げられる。
The photosensitizer (A) is preferably one having a tricyclic condensed ring (tricylic) from the viewpoint of obtaining an excellent photocatalytic action and being easily available. Examples of the tricyclic condensed ring include compounds having a skeleton such as anthracene, phenanthrene, fluorene, anthraquinone, xanthene, thioxanthene, xanthone, isoalloxazine, alloxazine, phenoxazine, fluorescein, thioxanthone, acridine, and phenothiazine, among which compounds having a skeleton selected from isoalloxazine, alloxazine, phenothiazine, fluorescein, anthraquinone, and acridine are preferred, and further, compounds having an isoalloxazine skeleton or an alloxazine skeleton are more preferred from the viewpoint of photocatalytic performance by visible light (e.g., wavelength 400 to 600 nm).
Specific examples of compounds having a phenothiazine skeleton include perfeazine, chlorpromazine, acepromazine, phenothiazine, methylphenothiazine, methylene blue, etc., and from the viewpoint of sustained release of the composition, perfeazine, chlorpromazine, or acepromazine is preferred.
Specific examples of compounds having a fluorescein skeleton include fluorescein, phloxine, dibromofluorescein, eosin Y, eosin B, rhodamine B, rhodamine 6G, and rose bengal. From the viewpoint of sustained release of the composition, fluorescein, phloxine, dibromofluorescein, eosin Y, eosin B, and rose bengal are preferred.
Specific examples of the compound having an anthraquinone skeleton include anthraquinonesulfonic acid, anthraquinonedisulfonic acid, anthraquinonecarboxylic acid, 2-anthraquinonesulfonic acid, and alkali metal salts thereof.
Specific examples of the compound having an acridine skeleton include acridine orange and acridine carboxylic acid.
イソアロキサジン骨格又はアロキサジン骨格を有する化合物としては、下記一般式(1)で表される化合物、又は下記一般式(2)で表される化合物が挙げられる。これらの化合物によれば、例えば白色LEDなど比較的出力の小さい光源を用いた場合でも優れた光触媒効果が得られる。 Compounds having an isoalloxazine skeleton or an alloxazine skeleton include compounds represented by the following general formula (1) and compounds represented by the following general formula (2). With these compounds, excellent photocatalytic effects can be obtained even when a light source with a relatively low output, such as a white LED, is used.
R1、R2、R3及びR4は、各々独立に、水素原子、ハロゲン原子、又は、置換基を有していてもよい炭化水素基であり、
R5及びR6は、各々独立に、水素原子、又は、置換基を有していてもよい炭化水素基であり、
式(2)中、
R11、R12、R13及びR14は、各々独立に、水素原子、ハロゲン原子、又は、置換基を有していてもよい炭化水素基であり、
R15及びR16は、各々独立に、水素原子、又は、置換基を有していてもよい炭化水素基である。
R 1 , R 2 , R 3 and R 4 each independently represent a hydrogen atom, a halogen atom or a hydrocarbon group which may have a substituent;
R5 and R6 each independently represent a hydrogen atom or a hydrocarbon group which may have a substituent;
In formula (2),
R 11 , R 12 , R 13 and R 14 each independently represent a hydrogen atom, a halogen atom or a hydrocarbon group which may have a substituent;
R 15 and R 16 each independently represent a hydrogen atom or a hydrocarbon group which may have a substituent.
R1~R4、R11~R14におけるハロゲン原子としては、フッ素原子、塩素原子、臭素原子などが挙げられる。
R1~R4、R11~R14における炭化水素基としては、炭素数1~6の直鎖又は分岐を有するアルキル基、置換基として直鎖又は分岐を有するアルキル基を有していてもよい炭素数6~12のシクロアルキル基又はアリール基などが挙げられる。直鎖又は分岐を有するアルキル基としては、メチル基、エチル基、n-ブチル基、tert-ブチル基、ヘキシル基などが挙げられる。シクロアルキル基としては、シクロヘキシル基などが挙げられる。またアリール基としてはフェニル基、ナフチル基などが挙げられる。R1~R4、R11~R14における炭化水素基が有していてもよい置換基としては、ヒドロキシ基、カルボキシ基、ハロゲン原子などが挙げられ、ヒドロキシ基、カルボキシ基は更にエステル化された誘導体であってもよい。
光触媒能の点から、R1、R4、R11及びR14は各々独立に水素原子であることが好ましい。また、光触媒能の点から、R2、R3、R12及びR13は各々独立に、置換基を有しない直鎖又は分岐を有するアルキル基が好ましく、炭素数1~4のアルキル基がより好ましく、メチル基が更に好ましい。
Examples of the halogen atom in R 1 to R 4 and R 11 to R 14 include a fluorine atom, a chlorine atom, and a bromine atom.
Examples of the hydrocarbon group in R 1 to R 4 and R 11 to R 14 include a linear or branched alkyl group having 1 to 6 carbon atoms, a cycloalkyl group or an aryl group having 6 to 12 carbon atoms which may have a linear or branched alkyl group as a substituent. Examples of the linear or branched alkyl group include a methyl group, an ethyl group, an n-butyl group, a tert-butyl group, and a hexyl group. Examples of the cycloalkyl group include a cyclohexyl group. Examples of the aryl group include a phenyl group and a naphthyl group. Examples of the substituent that the hydrocarbon group in R 1 to R 4 and R 11 to R 14 may have include a hydroxy group, a carboxy group, and a halogen atom, and the hydroxy group and the carboxy group may be further esterified derivatives.
From the viewpoint of photocatalytic activity, it is preferable that R 1 , R 4 , R 11 and R 14 are each independently a hydrogen atom. Also, from the viewpoint of photocatalytic activity, it is preferable that R 2 , R 3 , R 12 and R 13 are each independently an unsubstituted linear or branched alkyl group, more preferably an alkyl group having 1 to 4 carbon atoms, and further preferably a methyl group.
R6、R15及びR16における炭化水素基としては、前記R1等と同様のものが挙げられ、好ましい態様も同様である。光触媒能の点から、R6、R15及びR16は各々独立に水素原子が好ましい。 Examples of the hydrocarbon group in R 6 , R 15 and R 16 include the same as those in R 1 , etc., and the preferred embodiments are also the same. From the viewpoint of photocatalytic activity, it is preferable that R 6 , R 15 and R 16 are each independently a hydrogen atom.
R5における炭化水素基としては、前記R1等と同様のものが挙げられる。R5における炭化水素基が有していてもよい置換基としては、ヒドロキシ基又はそのエステル化体などが挙げられる。R5における置換基としては、中でも、リビチル基(-CH2-CHOH-CHOH-CHOH-CH2OH)又は、当該リビチル基のエステル化体が好ましい。 Examples of the hydrocarbon group in R5 include the same as those in R1 . Examples of the substituent that the hydrocarbon group in R5 may have include a hydroxyl group or an esterified product thereof. Among them, the substituent in R5 is preferably a ribityl group ( -CH2 -CHOH-CHOH-CHOH- CH2OH ) or an esterified product of the ribityl group.
更に前記イソアロキサジン骨格又はアロキサジン骨格を有する化合物は、リボフラビン又はリボフラビン誘導体が特に好ましい。リボフラビンはビタミンB2としても知られ、安全性が高く、例えば、本組成物を、土壌や大気中に散布する用途や、ヒトや生物の体内に取り込まれる可能性のある用途にも好適に用いることができる。
リボフラビン誘導体の具体例としては、リボフラビンテトラブチレート、リボフラビンテトラアセテート、ルミクローム(7,8-ジメチルアロキサジン)、リボフラビンリン酸エステル、及びその塩(ナトリウム塩、カリウム塩など)、フラビンアデニンジヌクレオチドなどが挙げられる。
Furthermore, the compound having an isoalloxazine skeleton or an alloxazine skeleton is particularly preferably riboflavin or a riboflavin derivative. Riboflavin is also known as vitamin B2 and is highly safe, and can be suitably used, for example, in applications where the composition is dispersed in soil or air, or where it may be taken up by humans or other living organisms.
Specific examples of riboflavin derivatives include riboflavin tetrabutyrate, riboflavin tetraacetate, lumichrome (7,8-dimethylalloxazine), riboflavin phosphate and its salts (sodium salt, potassium salt, etc.), flavin adenine dinucleotide, and the like.
光増感剤(A)はこれらの中でも、光触媒能、安全性、工業的入手の容易性などから、リボフラビン、リボフラビンテトラブチレート、ルミクローム、リボフラビンリン酸エステルナトリウムが好ましい。 Among these, riboflavin, riboflavin tetrabutylate, lumichrome, and riboflavin sodium phosphate are preferred as the photosensitizer (A) in terms of photocatalytic activity, safety, and ease of industrial availability.
<アミン化合物(B)>
アミン化合物(B)は、1分子中に少なくとも1個のアミノ基を有し、カルボン酸化合物(C)と塩形成し得る成分であり、また、光触媒作用により分解し得る成分である。
アミン化合物(B)中のアミノ基は、第1級アミノ基、第2級アミノ基、第3級アミノ基のいずれであってもよい。光触媒作用による分解性の点から、アミン化合物(B)は、アミノ基のα水素を有すること、即ち、アミノ基を構成する窒素原子に隣接する炭素原子が水素原子を有すること(アミン化合物(B)が「>N-CH<」の構造を有すること)が好ましい。
<Amine Compound (B)>
The amine compound (B) is a component which has at least one amino group in one molecule and can form a salt with the carboxylic acid compound (C), and which can be decomposed by the action of a photocatalyst.
The amino group in the amine compound (B) may be any of a primary amino group, a secondary amino group, and a tertiary amino group. From the viewpoint of decomposition by photocatalysis, it is preferable that the amine compound (B) has an α-hydrogen of the amino group, that is, the carbon atom adjacent to the nitrogen atom constituting the amino group has a hydrogen atom (the amine compound (B) has a structure of ">N-CH<").
また、本組成物を水溶液などとして使用する場合には、アミン化合物(B)とカルボン酸化合物(C)との塩形成物の溶解性などの点から、アミン化合物(B)がアミノ基と、親水性基を有することが好ましい。親水性基としては、アミノ基、グアニジノ基(-NHC(=NH)(-NH2))、カルボキシ基、ヒドロキシ基などが挙げられる。アミン化合物(B)中の親水性基は1個であっても2個以上であってもよい。また1分子中に2個以上の親水性基を有する場合、当該2個以上の親水性基は互いに同一であっても異なっていてもよい。なお、親水性基がアミノ基の場合、アミン化合物(B)は2個以上のアミノ基を有する。また、親水性基がカルボキシ基の場合、後述するカルボン酸化合物(C)にも含まれ得るが、本組成物中での作用を考慮しアミン化合物(B)に含めるものとする。 In addition, when the present composition is used as an aqueous solution, it is preferable that the amine compound (B) has an amino group and a hydrophilic group in terms of the solubility of the salt formed by the amine compound (B) and the carboxylic acid compound (C). Examples of the hydrophilic group include an amino group, a guanidino group (-NHC(=NH)(-NH 2 )), a carboxy group, and a hydroxy group. The hydrophilic group in the amine compound (B) may be one or more. When one molecule has two or more hydrophilic groups, the two or more hydrophilic groups may be the same or different. When the hydrophilic group is an amino group, the amine compound (B) has two or more amino groups. When the hydrophilic group is a carboxy group, it may also be included in the carboxylic acid compound (C) described later, but it is included in the amine compound (B) in consideration of its action in the present composition.
アミン化合物(B)は、低分子であってもよく、高分子であってもよい。なお本発明において、低分子とは分子量が1,000以下のものを表し、高分子とは分子量が1,000を超えるものを表すものとする。 The amine compound (B) may be a low molecular weight compound or a high molecular weight compound. In the present invention, a low molecular weight compound refers to a compound having a molecular weight of 1,000 or less, and a high molecular weight compound refers to a compound having a molecular weight of more than 1,000.
低分子のアミン化合物(B)は、光触媒作用による分解性、塩形成物の溶解性や、工業的入手性などの点から、中でも、アルカノールアミン、アミノ酸、又はアミノ糖が好ましい。
アルカノールアミンの具体例としては、モノエタノールアミン、ジエタノールアミン、トリエタノールアミン、N-メチルエタノールアミン、ジメチルエタノールアミン、N-エチルエタノールアミン、ジメチルエタノールアミン、モノイソプロパノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン、テトラヒドロキシプロピルエチレンジアミンなどが挙げられる。
アミノ酸の具体例としては、グリシン、アラニン、アルギニン、アスパラギン、アスパラギン酸、グルタミン、グルタミン酸、セリン、システイン、プロリン、チロシンなどが挙げられ、中でも塩基性アミノ酸が好ましく、アルギニンがより好ましい。
また、アミノ糖の具体例としては、グルコサミン、フルクトサミン、ガラクトサミン、マンノサミン、ペロサミン、シアル酸、ムラミン酸、ノイラミン酸などが挙げられ、中でもグルコサミンが好ましい。
Of the low molecular weight amine compounds (B), alkanolamines, amino acids, and amino sugars are preferred from the standpoints of decomposition by photocatalysis, solubility of salt-formed products, industrial availability, and the like.
Specific examples of alkanolamines include monoethanolamine, diethanolamine, triethanolamine, N-methylethanolamine, dimethylethanolamine, N-ethylethanolamine, dimethylethanolamine, monoisopropanolamine, diisopropanolamine, triisopropanolamine, and tetrahydroxypropylethylenediamine.
Specific examples of amino acids include glycine, alanine, arginine, asparagine, aspartic acid, glutamine, glutamic acid, serine, cysteine, proline, and tyrosine. Among these, basic amino acids are preferred, and arginine is more preferred.
Specific examples of amino sugars include glucosamine, fructosamine, galactosamine, mannosamine, perosamine, sialic acid, muramic acid, and neuraminic acid, with glucosamine being preferred.
低分子のアミン化合物(B)の分子量は、1,000以下であればよく、特に限定されないが、組成物中のアミン化合物(B)の割合を抑える点から、500以下が好ましく、300以下がより好ましい。アミン化合物(B)の分子量の下限値は特に限定されないが、通常、30以上である。 The molecular weight of the low molecular weight amine compound (B) is not particularly limited as long as it is 1,000 or less, but in order to suppress the proportion of the amine compound (B) in the composition, it is preferably 500 or less, and more preferably 300 or less. The lower limit of the molecular weight of the amine compound (B) is not particularly limited, but is usually 30 or more.
また高分子のアミン化合物(B)としては、質量当たりのアミノ基の数が多く、カルボン酸化合物(C)と塩形成しやすい点から、キトサン又はポリエチレンイミンが好ましい。 As the polymeric amine compound (B), chitosan or polyethyleneimine is preferred because it has a large number of amino groups per mass and is easy to form a salt with the carboxylic acid compound (C).
上記キトサンは、グルコサミン由来の構成単位を2個以上有し、アセチルグルコサミン由来の構成単位を有していてもよい化合物であり、更に他の構成を有していてもよい。また、キトサンオリゴ糖に分類され得る比較的低分子量の化合物であってもよい。当該キトサンとしては、光触媒能などの点から、中でも、複数のD-グルコサミンの1位と4位が結合して重合したキトサン(ポリ-1,4-β-D-グルコサミン)又はキトサンオリゴ糖が好ましい。キトサンは、グルコサミン由来の構成単位のみからなるポリグルコサミンであってもよく、N-アセチルグルコサミン由来の構成単位を有していてもよい。 The chitosan is a compound having two or more structural units derived from glucosamine, and may have structural units derived from acetylglucosamine, and may further have other structures. It may also be a relatively low molecular weight compound that can be classified as a chitosan oligosaccharide. In terms of photocatalytic activity, the chitosan is preferably chitosan (poly-1,4-β-D-glucosamine) or chitosan oligosaccharide, which is polymerized by bonding the 1-position and the 4-position of multiple D-glucosamines. The chitosan may be a polyglucosamine consisting only of structural units derived from glucosamine, or may have structural units derived from N-acetylglucosamine.
上記キトサンは、例えば、エビ、カニ、キノコ、昆虫、菌の細胞壁などから得られるキチンをアルカリで脱アセチル化することによって得られる。キトサンの脱アセチル化度は、光触媒効果の点や、光触媒効果の持続性のなどの点から50%以上が好ましく、70%以上がより好ましく、80%以上が更に好ましく、90%以上が特に好ましい。
なお、キトサンの脱アセチル化度は{グルコサミン由来の構成単位数/(グルコサミン由来の構成単位数+アセチルグルコサミン由来の構成単位数)}×100(%)を表し、例えば、ポリビニル硫酸カリウム(PVSK)を用いたコロイド滴定法などにより測定できる。
The chitosan can be obtained by deacetylating, with an alkali, chitin obtained from, for example, the cell walls of shrimp, crab, mushroom, insect, fungus, etc. The degree of deacetylation of chitosan is preferably 50% or more, more preferably 70% or more, even more preferably 80% or more, and particularly preferably 90% or more, from the standpoint of the photocatalytic effect and the durability of the photocatalytic effect.
The degree of deacetylation of chitosan is expressed as {number of structural units derived from glucosamine/(number of structural units derived from glucosamine+number of structural units derived from acetylglucosamine)}×100 (%) and can be measured, for example, by colloid titration using potassium polyvinyl sulfate (PVSK).
またキトサンは、キトサン誘導体を含んでいてもよい。キトサン誘導体としては、例えば、上記キトサンと、エチレンオキサイド、プロピレンオキサイド等のアルキレンオキサイドを反応させて得られる、ヒドロキシエチルキトサン等のヒドロキシアルキレンキトサン;
上記キトサンと、(1)モノクロロ酢酸とを反応させ、又は(2)グリオキサール酸を還元的アミノ化させて得られる、カルボキシメチル化キトサン;
上記キトサンにアジピン酸ジクロリド等のジクロリドを反応させて得られる架橋構造を有するキトサン等が挙げられる。
Chitosan may also contain a chitosan derivative, such as hydroxyalkylene chitosan, e.g., hydroxyethyl chitosan, which is obtained by reacting the chitosan with an alkylene oxide, e.g., ethylene oxide, propylene oxide, etc.;
a carboxymethylated chitosan obtained by reacting the chitosan with (1) monochloroacetic acid or (2) reductive amination of glyoxalic acid;
Examples of the chitosan include chitosan having a crosslinked structure obtained by reacting the above chitosan with a dichloride such as adipic acid dichloride.
キトサンの分子量は、5,000以上が好ましく、30,000以上がより好ましく、40,000以上が更に好ましい。一方、溶液の粘度を抑制する点から、キトサンの分子量は1,000,000以下が好ましく、500,000以下がより好ましく、200,000以下が更に好ましい。
なお本発明において高分子化合物の分子量は、水系ゲル濾過クロマトグラフィー(Chromaster(登録商標)、株式会社日立ハイテクサイエンス社製)により、標準プルラン換算値として求めたピークトップ分子量(Mp)である。
The molecular weight of chitosan is preferably 5,000 or more, more preferably 30,000 or more, and even more preferably 40,000 or more. On the other hand, in order to suppress the viscosity of the solution, the molecular weight of chitosan is preferably 1,000,000 or less, more preferably 500,000 or less, and even more preferably 200,000 or less.
In the present invention, the molecular weight of a polymer compound is the peak top molecular weight (Mp) determined as a standard pullulan equivalent value by aqueous gel filtration chromatography (Chromaster (registered trademark), manufactured by Hitachi High-Tech Science Corporation).
ポリエチレンイミンは、-CH2-CH2-NH-で表される構成単位、及び-CH2-CH2-N<で表される構成単位より選択される1種以上の構成単位を1分子中に2個以上有する化合物であり、直鎖状であっても分岐状であってもよく、デンドリマー型であってもよい。ポリエチレンイミンは、他の構成単位を有していてもよく、ポリエチレンイミン誘導体を含んでいてもよい。
ポリエチレンイミン誘導体としては、例えば、上記ポリエチレンイミンと、エチレンオキサイド、プロピレンオキサイド等のアルキレンオキサイドを反応させて得られる、ヒドロキシエチルポリエチレンイミン等のヒドロキシアルキレンポリエチレンイミン;
上記ポリエチレンイミンと、(1)モノクロロ酢酸とを反応させ、又は(2)グリオキサール酸を還元的アミノ化させて得られる、カルボキシメチル化ポリエチレンイミン;
上記ポリエチレンイミンにアジピン酸ジクロリド等のジクロリドを反応させて得られる架橋構造を有するポリエチレンイミン等が挙げられる。
Polyethyleneimine is a compound having two or more types of structural units selected from the structural unit represented by -CH 2 -CH 2 -NH- and the structural unit represented by -CH 2 -CH 2 -N< in one molecule, and may be linear or branched, or may be a dendrimer type. Polyethyleneimine may have other structural units and may contain a polyethyleneimine derivative.
Examples of the polyethyleneimine derivatives include hydroxyalkylene polyethyleneimines such as hydroxyethyl polyethyleneimine obtained by reacting the above-mentioned polyethyleneimine with an alkylene oxide such as ethylene oxide or propylene oxide;
A carboxymethylated polyethyleneimine obtained by reacting the polyethyleneimine with (1) monochloroacetic acid or (2) reductive amination of glyoxalic acid;
Examples of the polyethyleneimine include polyethyleneimine having a crosslinked structure obtained by reacting the above-mentioned polyethyleneimine with a dichloride such as adipic acid dichloride.
ポリエチレンイミンのピークトップ分子量(Mp)は、10,000以上が好ましく、25,000以上がより好ましい。一方、ポリエチレンイミンの分子量は合成の容易性などの点から、1,000,000以下が好ましく、800,000以下がより好ましく、500,000以下が更に好ましい。 The peak top molecular weight (Mp) of polyethyleneimine is preferably 10,000 or more, and more preferably 25,000 or more. On the other hand, from the viewpoint of ease of synthesis, the molecular weight of polyethyleneimine is preferably 1,000,000 or less, more preferably 800,000 or less, and even more preferably 500,000 or less.
ポリエチレンイミンは、例えばアジリジンを開環重合することにより合成することができる。また、ポリエチレンイミンは市販品を用いてもよい。 Polyethyleneimine can be synthesized, for example, by ring-opening polymerization of aziridine. Alternatively, commercially available polyethyleneimine may be used.
アミン化合物(B)は1種類を単独で、又は2種類以上を組み合わせて用いることができ、例えば低分子のアミン化合物(B)と高分子のアミン化合物(B)を組み合わせてもよい。 The amine compound (B) may be used alone or in combination of two or more types, for example, a low molecular weight amine compound (B) may be combined with a high molecular weight amine compound (B).
<カルボン酸化合物(C)>
カルボン酸化合物(C)は、1分子中に少なくとも1個のカルボキシ基を有する化合物である。本組成物中で、カルボン酸化合物(C)は、アミン化合物(B)と塩形成し、光照射により放出される成分である。なおカルボン酸化合物(C)はカルボキシ基以外の置換基を有していてもよいが、アミノ基を有するものは、前記アミン化合物(B)に含めるものとする。
<Carboxylic Acid Compound (C)>
The carboxylic acid compound (C) is a compound having at least one carboxy group in one molecule. In the present composition, the carboxylic acid compound (C) is a component that forms a salt with the amine compound (B) and is released by irradiation with light. The carboxylic acid compound (C) may have a substituent other than a carboxy group, but those having an amino group are included in the amine compound (B).
本組成物においてカルボン酸化合物(C)は徐放される機能性成分であり、本組成物の用途に応じて適宜選択すればよい。徐放を制御しやすい点からは1価のカルボン酸が好ましい。当該1価のカルボン酸としては、例えば、脂肪酸やケイ皮酸類が挙げられる。 In the present composition, the carboxylic acid compound (C) is a functional component that is sustained-released, and may be appropriately selected depending on the application of the present composition. From the viewpoint of ease of controlling sustained release, monovalent carboxylic acids are preferred. Examples of such monovalent carboxylic acids include fatty acids and cinnamic acids.
脂肪酸が有する炭化水素基は、直鎖であってもよく分岐を有していてもよい。また飽和脂肪酸であってもよく、不飽和脂肪酸であってもよい。
脂肪酸の具体例としては、酢酸、プロピオン酸、酪酸、ヘキサン酸、カプリル酸、イソノナン酸、ペラルゴン酸、カプリン酸、ネオデカン酸、ウンデセン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、アラキジン酸、パルミトオレイン酸、オレイン酸、エライジン酸、パクセン酸、リノール酸、リノレン酸、アラキドン酸、ドコサヘキサエン酸などが挙げられ、1種類を単独で又は2種類以上を組み合わせて用いることができる。また、アマニ油脂肪酸、桐油脂肪酸、ひまし油脂肪酸、大豆油脂肪酸、トール油脂肪酸、ヌカ油脂肪酸、パーム油脂肪酸、ヤシ油脂肪酸などを用いてもよい。
The hydrocarbon group of the fatty acid may be linear or branched, and may be saturated or unsaturated.
Specific examples of fatty acids include acetic acid, propionic acid, butyric acid, hexanoic acid, caprylic acid, isononanoic acid, pelargonic acid, capric acid, neodecanoic acid, undecenoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, palmitoleic acid, oleic acid, elaidic acid, paccenic acid, linoleic acid, linolenic acid, arachidonic acid, docosahexaenoic acid, etc., and one type may be used alone or two or more types may be used in combination. In addition, linseed oil fatty acid, tung oil fatty acid, castor oil fatty acid, soybean oil fatty acid, tall oil fatty acid, rice bran oil fatty acid, palm oil fatty acid, coconut oil fatty acid, etc. may also be used.
また、ケイ皮酸類としては、ケイ皮酸及びその誘導体が挙げられる。なお本発明において、「ケイ皮酸」はE体((2E)-3-phenyl-prop-2-enoic acid)とZ体((2Z)-3-phenyl-prop-2-enoic acid;アロケイ皮酸)を含む。 Cinnamic acids include cinnamic acid and its derivatives. In the present invention, "cinnamic acid" includes the E form ((2E)-3-phenyl-prop-2-enoic acid) and the Z form ((2Z)-3-phenyl-prop-2-enoic acid; allocinnamic acid).
ケイ皮酸及びその誘導体としては、下記式(11)で表される化合物が挙げられる。 Examples of cinnamic acid and its derivatives include the compound represented by the following formula (11).
R21~R25は、各々独立に、水素原子、ハロゲン原子、水酸基、炭素数1~6のアルキル基、又は、炭素数1~6のアルコキシ基である。
R 21 to R 25 each independently represent a hydrogen atom, a halogen atom, a hydroxyl group, an alkyl group having 1 to 6 carbon atoms, or an alkoxy group having 1 to 6 carbon atoms.
上記ハロゲン原子としては、フッ素原子、塩素原子、臭素原子が挙げられる。上記アルキル基としては、メチル基、エチル基、プロピル基、ブチル基、ペンチル基、ヘキシル基などが挙げられる。また上記アルコキシ基としては、メトキシ基、エトキシ基、プロポキシ基、ブトキシ基などが挙げられる。 The halogen atoms include fluorine, chlorine, and bromine atoms. The alkyl groups include methyl, ethyl, propyl, butyl, pentyl, and hexyl groups. The alkoxy groups include methoxy, ethoxy, propoxy, and butoxy groups.
ケイ皮酸及びその誘導体としては、中でも、ケイ皮酸、フェルラ酸、カフェ酸、クマル酸、シナピン酸などが好ましく、ケイ皮酸、フェルラ酸がより好ましい。 Of the cinnamic acid and its derivatives, cinnamic acid, ferulic acid, caffeic acid, coumaric acid, sinapic acid, etc. are preferred, with cinnamic acid and ferulic acid being more preferred.
カルボン酸化合物(C)は、1種類を単独で、又は2種類以上を組み合わせて用いることができる。 The carboxylic acid compound (C) can be used alone or in combination of two or more types.
カルボン酸化合物(C)を機能性成分とする用途としては、例えば、コケ除去剤、防カビ剤、農薬等の展着剤などが挙げられる。
本組成物をコケ除去剤として用いる場合、カルボン酸化合物(C)は、炭素数3~15の脂肪酸、又はケイ皮酸類が好ましく、中でも、炭素数6~15の脂肪酸、又はケイ皮酸類がより好ましい。
本組成物を防カビ剤として用いる場合、カルボン酸化合物(C)は、炭素数3~15の脂肪酸が好ましく、中でも、炭素数6~15の脂肪酸がより好ましい。
また本組成物を農薬の展着剤として用いる場合、カルボン酸化合物(C)は、脂肪酸が好ましく、炭素数8以上の脂肪酸がより好ましく、炭素数12~24の脂肪酸が更に好ましい。炭素数8以上の脂肪酸を用いることで、アミン化合物(B)と前記カルボン酸化合物(C)との塩と、放出後のカルボン酸化合物(C)単体とのHLB値の差が大きくなり、植物や害虫の表面に薬剤を付着させやすい。
Examples of applications in which the carboxylic acid compound (C) is used as a functional component include moss removers, antifungal agents, and spreaders for agricultural chemicals.
When the present composition is used as a moss-removing agent, the carboxylic acid compound (C) is preferably a fatty acid having 3 to 15 carbon atoms or a cinnamic acid, and among these, a fatty acid having 6 to 15 carbon atoms or a cinnamic acid is more preferred.
When the present composition is used as an antifungal agent, the carboxylic acid compound (C) is preferably a fatty acid having 3 to 15 carbon atoms, and among these, a fatty acid having 6 to 15 carbon atoms is more preferred.
Furthermore, when the present composition is used as a spreader for agricultural chemicals, the carboxylic acid compound (C) is preferably a fatty acid, more preferably a fatty acid having 8 or more carbon atoms, and even more preferably a fatty acid having 12 to 24 carbon atoms. By using a fatty acid having 8 or more carbon atoms, the difference in HLB value between the salt of the amine compound (B) and the carboxylic acid compound (C) and the simple carboxylic acid compound (C) after release becomes large, making it easier to attach the chemical to the surfaces of plants and pests.
本組成物は、カルボン酸化合物(C)の代わりに、又は、カルボン酸化合物(C)と併用して、他の酸性化合物を用いてもよい。他の酸性化合物は、アミン化合物(B)と塩形成し得るものであればよく、例えば、スルホン酸化合物、酸性リン酸エステルなどが挙げられる。
スルホン酸化合物は、1分子中に少なくとも1個のスルホ基を有する化合物であり、有機酸が好ましい。スルホン酸化合物の具体例としては、オクタンスルホン酸、ドデカンスルホン酸、ヘキサデカンスルホン酸などのアルキルスルホン酸;デシルベンゼンスルホン酸、ドデシルベンゼンスルホン酸、トリデシルベンゼンスルホン酸などのアルキルベンゼンスルホン酸;ドデシル硫酸、ラウリル硫酸などのアルキル硫酸エステル;ポリオキシエチレンラウリルエーテル硫酸、ポリオキシエチレンイソトリデシル硫酸などのアルキルエーテル硫酸等が挙げられる。
また、酸性リン酸エステルは、分子内にP-OHと、リン酸エステル構造を有する化合物である。酸性リン酸エステルの具体例としては、イソトリデシルアシッドホスフェート、オレイルアシッドホスフェートなどのアルキルリン酸エステルや、エチレングリコールアシッドホスフェートなどが挙げられる。これらの酸性化合物は、上記展着剤として好適に用いることができる。
The composition may contain other acidic compounds in place of or in combination with the carboxylic acid compound (C). The other acidic compounds may be any compounds capable of forming a salt with the amine compound (B), and examples of such compounds include sulfonic acid compounds and acidic phosphate esters.
The sulfonic acid compound is a compound having at least one sulfo group in one molecule, and is preferably an organic acid.Specific examples of the sulfonic acid compound include alkyl sulfonic acids such as octanesulfonic acid, dodecanesulfonic acid, and hexadecanesulfonic acid; alkyl benzene sulfonic acids such as decyl benzene sulfonic acid, dodecyl benzene sulfonic acid, and tridecyl benzene sulfonic acid; alkyl sulfates such as dodecyl sulfate and lauryl sulfate; alkyl ether sulfates such as polyoxyethylene lauryl ether sulfate and polyoxyethylene isotridecyl sulfate.
An acidic phosphate ester is a compound having a P-OH and a phosphate ester structure in the molecule. Specific examples of acidic phosphate esters include alkyl phosphate esters such as isotridecyl acid phosphate and oleyl acid phosphate, and ethylene glycol acid phosphate. These acidic compounds can be suitably used as the spreading agent.
(各成分の含有割合)
本組成物中の光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)の含有割合は、用途に応じて適宜調整すればよい。
光増感剤(A)の割合は、光照射量に対する機能性成分の発生量と、効果の持続性を考慮して例えば、光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)の合計質量100質量%に対して、0.1×10-5質量%~40質量%の範囲で適宜調整できる。
本組成物の効果の持続性の点、及び本組成物のコストメリットの点からは、光増感剤(A)の前記合計質量に対する割合は、40質量%以下が好ましく、30質量%以下がより好ましく、10質量%以下が更に好ましく、5質量%以下が特に好ましく、0.5質量%以下が極めて好ましい。なお、本組成物は光増感剤(A)が比較的高濃度(例えば30質量%以上)であっても、日光を当てた際、カルボン酸化合物(C)を一度に放出することなく、機能性成分の効果が持続できる。
また、本組成物を光応答性に優れた徐放性組成物とする点からは、前記光増感剤(A)の前記割合は、0.1×10-5質量%以上が好ましく、0.2×10-4質量%以上がより好ましく、0.1×10-3質量%以上が更に好ましい。
(Content of each component)
The content ratio of the photosensitizer (A), the amine compound (B) and the carboxylic acid compound (C) in the present composition may be appropriately adjusted depending on the application.
The proportion of the photosensitizer (A) can be appropriately adjusted, for example, within a range of 0.1 × 10-5% by mass to 40 % by mass relative to 100% by mass, which is the total mass of the photosensitizer (A), the amine compound (B), and the carboxylic acid compound (C), taking into consideration the amount of functional component generated relative to the amount of light irradiation and the duration of the effect.
From the viewpoint of the durability of the effect of the present composition and the viewpoint of the cost merit of the present composition, the ratio of the photosensitizer (A) to the total mass is preferably 40 mass% or less, more preferably 30 mass% or less, even more preferably 10 mass% or less, particularly preferably 5 mass% or less, and extremely preferably 0.5 mass% or less. Even if the present composition has a relatively high concentration of the photosensitizer (A) (e.g., 30 mass% or more), the effect of the functional component can be sustained when exposed to sunlight without releasing the carboxylic acid compound (C) all at once.
From the viewpoint of making the present composition a sustained-release composition having excellent photoresponsiveness, the ratio of the photosensitizer (A) is preferably 0.1× 10-5 % by mass or more, more preferably 0.2× 10-4 % by mass or more, and even more preferably 0.1× 10-3 % by mass or more.
本組成物に含まれる、前記アミン化合物(B)が有するアミノ基と前記カルボン酸化合物(C)が有するカルボキシ基とのモル比(アミノ基/カルボキシ基)は1.0以上が好ましく、1.2以上がより好ましく、1.5以上が更に好ましい。上記モル比が1.0以上であれば、組成物中のカルボン酸化合物(C)の多くが塩形成しているため、機能性成分の効果を長期間持続することができる。上記モル比の上限は特に限定されないが、例えば3.0以下で十分であり、2.5以下が好ましく、2.0以下がより好ましい。
また、アミン化合物(B)と、カルボン酸化合物(C)のモル比(アミン化合物(B)/カルボン酸化合物(C))は、1.0~3.0が好ましく、1.2~2.5がより好ましく、1.5~2.0が更に好ましい。組成物中のアミノ基とカルボキシ基のモル比は、組成物のアミン価及び酸価から求めることができる。
The molar ratio (amino group/carboxy group) of the amino group of the amine compound (B) and the carboxy group of the carboxylic acid compound (C) contained in this composition is preferably 1.0 or more, more preferably 1.2 or more, and even more preferably 1.5 or more. If the molar ratio is 1.0 or more, most of the carboxylic acid compound (C) in the composition is in salt form, so the effect of the functional component can be maintained for a long period of time. The upper limit of the molar ratio is not particularly limited, but for example, 3.0 or less is sufficient, preferably 2.5 or less, and more preferably 2.0 or less.
The molar ratio of the amine compound (B) to the carboxylic acid compound (C) (amine compound (B)/carboxylic acid compound (C)) is preferably from 1.0 to 3.0, more preferably from 1.2 to 2.5, and even more preferably from 1.5 to 2.0. The molar ratio of amino groups to carboxy groups in the composition can be determined from the amine value and acid value of the composition.
<任意成分>
本組成物は本発明の効果を奏する範囲で他の成分を含有してもよい。他の成分としては、溶媒や、界面活性剤、ゲル化剤、消泡剤、防腐剤、pH調整剤などの各種添加剤が挙げられる。
<Optional ingredients>
The composition may contain other components within the range in which the effects of the present invention are achieved, such as solvents and various additives such as surfactants, gelling agents, antifoaming agents, preservatives, and pH adjusters.
溶媒としては、本組成物の各成分を溶解又は分散するものの中から適宜選択して用いることができる。各成分が溶解又は分散しやすい点から、溶媒として、水及び水溶性溶媒より選択される1種以上の溶媒を含むことが好ましく、水を含むことがより好ましい。水溶性溶媒としては、エタノール、イソプロパノール、エチレングリコール、プロピレングリコール、グリセリン、ジプロピレングリコール、ジエチレングリコール等のアルコール系溶媒などが挙げられる。
水と水溶性溶媒との混合溶媒を用いる場合、溶媒100質量%中、水溶性溶媒は10質量%以下が好ましく、5質量%以下が好ましい。更に、溶媒は、種々の用途に使用可能な点あら、実質的に水のみからなる溶媒であることが好ましい。
例えば水を含む本組成物は、カルボン酸化合物(C)がアミン化合物(B)を塩形成している際は溶解し、アミン化合物(B)が分解されるとカルボン酸化合物(C)が析出する形態とすることもできる。また、溶媒を含む本組成物は、土壌への散布や、壁面への塗布など取り扱い性に優れている。
The solvent can be appropriately selected from those that dissolve or disperse each component of the composition. In terms of ease of dissolving or dispersing each component, the solvent preferably contains one or more solvents selected from water and water-soluble solvents, and more preferably contains water. Examples of the water-soluble solvent include alcohol-based solvents such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerin, dipropylene glycol, and diethylene glycol.
When a mixed solvent of water and a water-soluble solvent is used, the content of the water-soluble solvent is preferably 10% by mass or less, more preferably 5% by mass or less, based on 100% by mass of the solvent. Furthermore, the solvent is preferably a solvent consisting essentially of water, since it can be used for various purposes.
For example, the present composition containing water can be in a form in which the carboxylic acid compound (C) dissolves when the amine compound (B) forms a salt, and the carboxylic acid compound (C) precipitates when the amine compound (B) is decomposed. The present composition containing a solvent is also easy to handle, for example, when it is sprayed on soil or applied to a wall surface.
界面活性剤は、基材等への濡れ性を付与することなどを目的に用いられ、用途に応じて、アニオン系界面活性剤、ノニオン系界面活性剤、カチオン系界面活性剤など、公知の界面活性剤の中から適宜選択して用いることができる。 Surfactants are used for purposes such as imparting wettability to substrates, and can be appropriately selected from known surfactants such as anionic surfactants, nonionic surfactants, and cationic surfactants depending on the application.
また本組成物はゲル化剤を含有し、ゲル状の形態として用いてもよい。ゲル化剤としては、食品用途にも用いられ、環境負荷を抑える点から、ゼラチン、増粘性多糖類又はこれらの架橋物が好ましい。なお、ゲル化剤を用いる場合、組成物は水を含有することが好ましい。なおゲル化剤がカルボキシ基を有する場合も、機能性を考慮して上記カルボン酸化合物(C)には含めないものとする。 The composition may also contain a gelling agent and be used in the form of a gel. As gelling agents, gelatin, thickening polysaccharides, or crosslinked products thereof are preferred, as they are also used in food applications and reduce the environmental impact. When a gelling agent is used, it is preferred that the composition contains water. Even if the gelling agent has a carboxy group, it is not included in the above carboxylic acid compound (C) in consideration of functionality.
上記ゼラチンは、コラーゲンを水と煮沸して水溶性とした蛋白質変性物を表し、例えば、牛、豚、魚類など各種の動物種の皮膚、骨、腱などの部位から採取できるコラーゲンをアルカリ加水分解、酸加水分解、及び酵素分解等の種々の処理によって変性させたものなどが挙げられる。
また増粘多糖類は、糖類の重合体であり分子内に水素結合基を多数有するものでゲル化し得るものをいう。増粘性多糖類は、一般に知られている天然単純多糖類、天然複合多糖類、合成単純多糖類及び合成複合多糖類の中から用途に合わせて適宜選択して用いることができる。増粘性多糖類の具体例としては、デンプン、グリコーゲン、アガロース、アガロペクチン、カラギーナン、ペクチン、キサンタンガム、ローカストビーンガム、グァーガム、ジェランガム、アラビアガム、アルギン酸、ヘミセルロース、タラガム、タマリンドシードガム、キチン、キトサン、グルコマンナンなどが挙げられ、アガロースとアガロペクチンの混合物である寒天などであってもよい。
The above-mentioned gelatin refers to a denatured protein obtained by boiling collagen in water to make it water-soluble. For example, collagen that can be collected from the skin, bones, tendons, and other parts of various animal species such as cows, pigs, and fish is denatured by various processes such as alkaline hydrolysis, acid hydrolysis, and enzymatic decomposition.
The thickening polysaccharide is a polymer of saccharides having many hydrogen bond groups in the molecule and capable of gelling. The thickening polysaccharide can be appropriately selected from commonly known natural simple polysaccharides, natural complex polysaccharides, synthetic simple polysaccharides, and synthetic complex polysaccharides according to the purpose. Specific examples of the thickening polysaccharide include starch, glycogen, agarose, agaropectin, carrageenan, pectin, xanthan gum, locust bean gum, guar gum, gellan gum, gum arabic, alginic acid, hemicellulose, tara gum, tamarind seed gum, chitin, chitosan, glucomannan, and the like, and may also be agar, which is a mixture of agarose and agaropectin.
<組成物の調製方法>
本組成物の調製方法は、前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成するように混合すればよく、具体的には、例えば、(I)水及び/又は水溶性溶媒に、アミン化合物(B)とカルボン酸化合物(C)とを添加して混合することで塩形成させた後に、光増感剤(A)と、必要に応じて用いられる他の成分を添加する方法;(II)水及び/又は水溶性溶媒に、光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)と、必要に応じて用いられる他の成分を添加して混合することで、アミン化合物(B)とカルボン酸化合物(C)とを塩形成させながら組成物を調製する方法などが挙げられる。
また、上記の方法で高濃度の組成物を調製し、使用時に水等の溶媒で希釈して用いてもよい。
本組成物を展着剤として用いる場合は、上記調製後の組成物に、公知の乳剤と、農薬等の薬剤を添加して用いることができる。
<Method of preparing the composition>
The method for preparing the present composition may be any method as long as the amine compound (B) and the carboxylic acid compound (C) are mixed so that at least a part of them forms a salt. Specific examples of the method include (I) a method in which the amine compound (B) and the carboxylic acid compound (C) are added to water and/or a water-soluble solvent and mixed to form a salt, and then the photosensitizer (A) and other components used as necessary are added; and (II) a method in which the photosensitizer (A), the amine compound (B), the carboxylic acid compound (C), and other components used as necessary are added to water and/or a water-soluble solvent and mixed to prepare a composition while forming a salt between the amine compound (B) and the carboxylic acid compound (C).
Alternatively, a highly concentrated composition may be prepared by the above method, and then diluted with a solvent such as water when in use.
When the present composition is used as a spreading agent, a known emulsifiable concentrate and a chemical such as an agricultural chemical can be added to the composition after the above preparation.
本組成物は、光照射によりカルボン酸化合物(C)を徐放する徐放性組成物として、好適に用いることができる。光増感剤(A)の含有量を調整することで直射日光照射下においてもカルボン酸化合物(C)を一度に放出することなく徐放性を有する組成物とすることができる。また、光増感剤(A)の選択により、例えば、白色LEDなど比較的出力の小さい光源を用いた場合でも優れた徐放性が得られる。
本組成物は、カルボン酸化合物を機能性成分とする公知の用途に適用することができ、例えば、室外などにおけるコケの除去剤;冷却塔(クーリングタワー)の循環液として又は循環液へ添加して用いる、コケ発生抑制剤;物品表面や気相中の防カビ剤などとして好適に用いることができる。
This composition can be suitably used as a sustained release composition that releases the carboxylic acid compound (C) by light irradiation. By adjusting the content of the photosensitizer (A), the composition can be made to have sustained release properties without releasing the carboxylic acid compound (C) all at once even under direct sunlight irradiation. In addition, by selecting the photosensitizer (A), excellent sustained release properties can be obtained even when a light source with a relatively low output, such as a white LED, is used.
The present composition can be applied to known applications in which a carboxylic acid compound is a functional component, and can be suitably used, for example, as a moss remover for outdoors, etc.; a moss growth inhibitor used as a circulating fluid for a cooling tower or added to the circulating fluid; and a mold inhibitor for the surface of an article or in the gas phase.
以下に実施例及び比較例を挙げて、本発明について具体的に説明するが、本発明はこれら実施例に限定されるものではない。なお、以下「ppm」は「μg/g」を表す。 The present invention will be specifically explained below with reference to examples and comparative examples, but the present invention is not limited to these examples. In the following, "ppm" stands for "μg/g."
[光増感剤(A)]
光増感剤として下記(A1)~(A7)を使用した。
・(A1):リボフラビン
・(A2):リボフラビンリン酸エステルナトリウム
・(A3):ルミクローム
・(A4):ローズベンガル
・(A5):エオシンY
・(A6):アクリジンオレンジ
・(A7):2-アントラキノンスルホン酸ナトリウム
[Photosensitizer (A)]
The following (A1) to (A7) were used as photosensitizers.
(A1): Riboflavin (A2): Riboflavin phosphate sodium (A3): Lumichrome (A4): Rose Bengal (A5): Eosin Y
(A6): Acridine orange (A7): Sodium 2-anthraquinonesulfonate
[アミン化合物(B)]
アミン化合物として下記(B1)~(B6)を使用した。
・(B1):L-アルギニン
・(B2):モノイソプロパノールアミン
・(B3):ジエタノールアミン
・(B4):トリエタノールアミン
・(B5):トリイソプロパノールアミン
・(B6):テトラヒドロキシプロピルエチレンジアミン
[Amine compound (B)]
As the amine compounds, the following (B1) to (B6) were used.
(B1): L-arginine (B2): monoisopropanolamine (B3): diethanolamine (B4): triethanolamine (B5): triisopropanolamine (B6): tetrahydroxypropylethylenediamine
[カルボン酸化合物(C)]
カルボン酸化合物として下記(C1)~(C11)を使用した。
・(C1):ヘキサン酸
・(C2):カプリル酸
・(C3):イソノナン酸
・(C4):ペラルゴン酸
・(C5):カプリン酸
・(C6):ネオデカン酸
・(C7):ウンデセン酸
・(C8):ラウリン酸
・(C9):ミリスチン酸
・(C10):ヤシ油脂肪酸(炭素数8~12の脂肪酸を含む)
・(C11):フェルラ酸
[Carboxylic Acid Compound (C)]
As the carboxylic acid compounds, the following (C1) to (C11) were used.
(C1): Hexanoic acid, (C2): Caprylic acid, (C3): Isononanoic acid, (C4): Pelargonic acid, (C5): Capric acid, (C6): Neodecanoic acid, (C7): Undecenoic acid, (C8): Lauric acid, (C9): Myristic acid, (C10): Coconut oil fatty acid (containing fatty acids with 8 to 12 carbon atoms)
(C11): Ferulic acid
[実施例1:組成物の調製]
リボフラビン5ppm相当と、テトラヒドロキシプロピルエチレンジアミン2.3質量%相当と、ヘキサン酸1.3質量%相当とを混合し、水を加えて表1に記載の組成となるように調製し、実施例1の組成物を得た。なお表1~3中、光増感剤(A)の数値はppmを表し、他の成分の数値は質量%を表す。
Example 1: Preparation of composition
Riboflavin (5 ppm equivalent), tetrahydroxypropylethylenediamine (2.3 mass %), and hexanoic acid (1.3 mass %) were mixed, and water was added to prepare the composition shown in Table 1, to obtain the composition of Example 1. In Tables 1 to 3, the numerical value of the photosensitizer (A) represents ppm, and the numerical values of the other components represent mass %.
[実施例2~31、比較例1~9:組成物の調製]
実施例1において、配合する各成分及びその配合量を表1~表3に記載の組成となるように変更した以外は、実施例1と同様にして、各組成物を調製した。
[Examples 2 to 31 and Comparative Examples 1 to 9: Preparation of Compositions]
Each composition was prepared in the same manner as in Example 1, except that the components and their amounts were changed so as to obtain the compositions shown in Tables 1 to 3.
[評価]
<コケ除去性>
コンクリートに自生しているホソウリゴケ(ハリガネゴケ科)をマスキングテープで囲い、各10cm×10cmの区画を設けた。実施例1の組成物の5mLを、1区画にスプレーで散布した。同様にしてもう1区画にも実施例1の組成物のスプレー散布を行った。
スプレー散布を行ったうちの1区画は下記暗条件、もう1区画は下記明条件とし、4日間保持し、コンクリート表面がむき出しになった面積(露出面積)の割合から下記評価基準に従い5段階で評価した。また、明条件の露出面積/暗条件の露出面積(コンクリート露出面積比)を算出した。実施例2~23及び比較例1~5の組成物も同様の試験を行った。結果を表1~2に示す。
暗条件:アルミ箔で表面を覆い、光を遮った。
明条件:アルミ箔で覆わずに太陽光が当たる状態とした。
(評価基準)
◎:100%のコンクリート露出
〇:80%以上100%未満のコンクリート露出
△:50%以上80%未満のコンクリート露出
▲:30%以上50%未満のコンクリート露出
×:30%未満のコンクリート露出
[evaluation]
<Moss removal>
A moss growing naturally on concrete was surrounded by masking tape to provide sections of 10 cm x 10 cm each. 5 mL of the composition of Example 1 was sprayed onto one section. The composition of Example 1 was sprayed onto the other section in the same manner.
One of the sections sprayed was kept under the dark conditions described below, and the other was kept under the light conditions described below for four days, and the ratio of the area of the concrete surface exposed (exposed area) was evaluated on a five-point scale according to the following evaluation criteria. In addition, the ratio of the exposed area under light conditions to the exposed area under dark conditions (exposed concrete area ratio) was calculated. The compositions of Examples 2 to 23 and Comparative Examples 1 to 5 were also subjected to the same test. The results are shown in Tables 1 and 2.
Dark conditions: The surface was covered with aluminum foil to block light.
Light condition: The sample was exposed to sunlight without being covered with aluminum foil.
(Evaluation criteria)
◎: 100% concrete exposed. ◯: 80% or more but less than 100% concrete exposed. △: 50% or more but less than 80% concrete exposed. ▲: 30% or more but less than 50% concrete exposed. ×: Less than 30% concrete exposed.
<気相防カビ性>
図1を参照して気相防カビ性試験方法を説明する。カビは、黒黴(NBRC9455)を用いた。深型の滅菌シャーレ20(深さ2cm、直径90mm)に、オートクレーブで滅菌溶解した培地21(ツァペックドックス寒天培地、CDA培地)を注入し,固化させた。ここに白金耳を用いて上記カビの混濁液を描線塗布した。
一方、別の滅菌シャーレ10(直径60mm)に実施例24の組成物11を5mL分注した。
図1のようにシャーレ20に対応する蓋30に、シャーレ10を静置し、シャーレ20をかぶせ、シャーレ20と蓋30の外周をビニールテープで密封した。これを2セット作成した。一方を下記暗条件、もう一方を下記明条件とし、20℃の条件下で5日間培養し、培地上の菌糸を目視で観察した。実施例25~31及び比較例5~9も同様にして評価を行った。結果を表3に示す。
暗条件:暗所で培養した。
明条件:白色LEDを用い、1,000lxの強度で1日あたり16時間光照射を行った。
(評価基準)
◎:カビの育成を十分に阻害した。
〇:カビの育成をある程度阻害した。
×:カビの育成を阻害できなかった。
<Vapor phase mold resistance>
The gas-phase antifungal test method will be described with reference to Fig. 1. The mold used was black mold (NBRC9455). A medium 21 (Czapek-Dox agar medium, CDA medium) sterilized and dissolved in an autoclave was poured into a deep sterilized petri dish 20 (
On the other hand, 5 mL of
As shown in Fig. 1, the
Dark conditions: Cultured in the dark.
Light conditions: A white LED was used, and light was irradiated at an intensity of 1,000 lx for 16 hours per day.
(Evaluation criteria)
⊚: Mold growth was sufficiently inhibited.
◯: Mold growth was inhibited to some extent.
×: Mold growth could not be inhibited.
[結果のまとめ]
アミン化合物(B)とカルボン酸化合物(C)を含有するが、光増感剤(A)を含有しない比較例3の組成物は、明条件と暗条件でコケ除去性が同等であった。比較例3の組成物に抗菌剤として知られているチモールを添加した組成を有する比較例4も、明条件と暗条件でコケ除去性が同等であった。これに対し、光増感剤(A)とアミン化合物(B)とカルボン酸化合物(C)を含有する実施例1~23の組成物は、いずれもコンクリート露出面積比が1.1以上であり、光照射下でコケ除去性が向上していることが示された。比較例1に示される通り、アミン化合物(B)の代わりに水酸化カリウムを用いた場合にはこの効果は得られなかった。
気相防カビ性に関し、その効果はより顕著にみられ、光増感剤(A)とアミン化合物(B)とカルボン酸化合物(C)を含有する実施例24~31の組成物は、光照射により発生したカルボン酸が揮発して培地に到達し、カビの育成を阻害したものと推定される。
[Summary of results]
The composition of Comparative Example 3, which contains an amine compound (B) and a carboxylic acid compound (C) but does not contain a photosensitizer (A), had the same moss removal properties under light and dark conditions. Comparative Example 4, which has a composition in which thymol, a known antibacterial agent, was added to the composition of Comparative Example 3, also had the same moss removal properties under light and dark conditions. In contrast, the compositions of Examples 1 to 23, which contain a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C), all had a concrete exposed area ratio of 1.1 or more, indicating that the moss removal properties were improved under light irradiation. As shown in Comparative Example 1, this effect was not obtained when potassium hydroxide was used instead of the amine compound (B).
With regard to the gas-phase antifungal effect, the effect was more remarkable, and it is presumed that in the compositions of Examples 24 to 31 containing a photosensitizer (A), an amine compound (B) and a carboxylic acid compound (C), the carboxylic acid generated by irradiation with light was vaporized and reached the medium, inhibiting the growth of mold.
[実施例32:気相防カビゲルの製造]
リボフラビン5ppm相当と、テトラヒドロキシプロピルエチレンジアミン1.5質量%相当と、カプリル酸0.8質量%相当と、ゲル化剤(伊那食品工業社製「カリコリカン」(寒天))0.8質量%相当を混合し、水を加えて実施例32のゲル状組成物を得た。
図2を参照して気相防カビ性試験方法を説明する。深型の滅菌シャーレ20(深さ2cm、直径90mm)に、オートクレーブで滅菌溶解したポテトデキストロース寒天培地21を20ml注入し、固化させた。ここに黒黴(NBRC9455)懸濁液を一文字に描線塗布した。
上記のシャーレ20と、ゲル状組成物11の9gを体積(200mm×170mm×30mm)の容器に収容し蓋をした。これを2セット作成した。またシャーレ20のみを収容し、ゲル状組成物を収容しないものも作成した。
一方を下記暗条件、もう一方と、ゲル状組成物を収容しないものを下記明条件の条件下20℃で7日間培養し、培地上の菌糸を目視で観察した。
暗条件:暗所で培養した。
明条件:白色LEDを用い、500lxの強度で1日あたり16時間光照射を行った。
上記試験の結果、暗条件及びゲル状組成物を収容しないものは、カビの育成が確認されたのに対し、明条件では、カビの育成を十分に阻害されていることが確認された。
以上の通り、本組成物はゲル状とした場合でも効果が確認され、例えば、食品と共に容器内に収容することで、食品の鮮度維持などの効果を奏することができる。
[Example 32: Production of vapor phase antifungal gel]
5 ppm of riboflavin, 1.5% by mass of tetrahydroxypropylethylenediamine, 0.8% by mass of caprylic acid, and 0.8% by mass of a gelling agent (Ina Food Industry Co., Ltd.'s "Calicolican" (agar)) were mixed together, and water was added to obtain the gel composition of Example 32.
The vapor-phase antifungal activity test method will be described with reference to Fig. 2. 20 ml of potato
The above-mentioned
One of the cultures was cultured under the dark conditions described below, and the other and the one not containing the gel composition were cultured under the light conditions described below at 20° C. for 7 days, and the mycelium on the medium was visually observed.
Dark conditions: Cultured in the dark.
Light conditions: A white LED was used, and light was irradiated at an intensity of 500 lx for 16 hours per day.
As a result of the above test, it was confirmed that mold growth occurred under dark conditions and in the case where the gel composition was not placed, whereas it was confirmed that mold growth was sufficiently inhibited under light conditions.
As described above, the effectiveness of the present composition has been confirmed even when made into a gel. For example, by storing the composition in a container together with food, it can have the effect of maintaining the freshness of the food.
[試験例1:光照射によるアミンの分解]
トリエタノールアミン1%水溶液に、リボフラビン50ppm相当を添加して試験液を調製した。当該試験液に青色LEDを5,500lxで照射し、トリエタノール量をイオンクロマトグラフィーにより測定した。対照実験として、リボフラビンを添加していないトリエタノールアミン1%水溶液に対しても同様に光照射を行った。結果を図3に示す。
図3に示される通り、光増感剤(A)とアミン化合物(B)を含有する組成物に光照射を行うことで、アミン化合物(B)が分解されている。
[Test Example 1: Decomposition of amine by light irradiation]
A test solution was prepared by adding 50 ppm of riboflavin to a 1% aqueous solution of triethanolamine. The test solution was irradiated with a blue LED at 5,500 lx, and the amount of triethanol was measured by ion chromatography. As a control experiment, a 1% aqueous solution of triethanolamine without added riboflavin was also irradiated with light in the same manner. The results are shown in Figure 3.
As shown in FIG. 3, the amine compound (B) is decomposed by irradiating a composition containing a photosensitizer (A) and an amine compound (B) with light.
[試験例2:光照射によるカルボン酸化合物の発生]
リボフラビン20ppm相当と、トリイソプロパノールアミン1.77質量%相当と、イソノナン酸0.8質量%相当と水を混合し、試験液を調製した。当該試験液の5mLをバイアル瓶に採取し、試験液に下記の条件で光照射を行った。光照射前後のバイアルの気相をヘッドスペースガスクロマトグラフ分析法により測定した。
光照射後のイソノナン酸にアサインされるピークの面積は、光照射前の1.32倍であった。
<光照射条件>
白色LEDを500lxで5時間照射した。
<ガスクロマトグラフィー条件>
ヘッドスペースサンプラー:アジレントテクノロジー製 7697A
カラム:HP-5MS(内径0.25mm,30m,膜厚0.25μm)
キャリアーガス:ヘリウム(2.0ml/min)
[Test Example 2: Generation of Carboxylic Acid Compounds by Irradiation with Light]
A test solution was prepared by mixing 20 ppm equivalent of riboflavin, 1.77 mass % equivalent of triisopropanolamine, 0.8 mass % equivalent of isononanoic acid, and water. 5 mL of the test solution was placed in a vial and irradiated with light under the following conditions. The gas phase of the vial before and after irradiation was measured by headspace gas chromatography analysis.
The area of the peak assigned to isononanoic acid after light irradiation was 1.32 times that before light irradiation.
<Light irradiation conditions>
The white LED was irradiated at 500 lx for 5 hours.
<Gas chromatography conditions>
Headspace sampler: Agilent Technologies 7697A
Column: HP-5MS (inner diameter 0.25 mm, 30 m, film thickness 0.25 μm)
Carrier gas: Helium (2.0 ml/min)
試験例1と試験例2の結果から、光増感剤(A)とアミン化合物(B)とカルボン酸化合物(C)を含有する組成物に光を照射すると、カルボン酸化合物(C)と塩形成しているアミン化合物(B)の分解が促進され、カルボン酸化合物(C)が放出するものと推定される。
以上のことから、光増感剤(A)と、アミン化合物(B)と、カルボン酸化合物(C)とを含有し、前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成している、本発明の組成物は、光照射により、前記カルボン酸化合物(C)を徐放することが示された。
From the results of Test Examples 1 and 2, it is presumed that when a composition containing a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C) is irradiated with light, the decomposition of the amine compound (B) that forms a salt with the carboxylic acid compound (C) is promoted, resulting in the release of the carboxylic acid compound (C).
From the above, it has been demonstrated that the composition of the present invention, which contains a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C), in which at least a part of the amine compound (B) and the carboxylic acid compound (C) form a salt, gradually releases the carboxylic acid compound (C) by light irradiation.
本発明に係る組成物は、光の照射によりカルボン酸化合物(C)を徐放するものであり、カルボン酸化合物を機能性成分とし効果を持続させることが望ましい、コケ除去剤、防カビ材、抗菌剤、香料などとして、好適に用いることができる。 The composition according to the present invention slowly releases a carboxylic acid compound (C) when irradiated with light, and can be suitably used as a moss remover, antifungal material, antibacterial agent, fragrance, etc., in which it is desirable to use a carboxylic acid compound as a functional component and to prolong its effect.
10…シャーレ、11…組成物、12…ゲル状組成物、20…シャーレ、21…培地、30…蓋、40…容器。 10: Petri dish, 11: composition, 12: gel composition, 20: petri dish, 21: culture medium, 30: lid, 40: container.
Claims (9)
前記光増感剤(A)が、イソアロキサジン及びアロキサジンより選択される骨格を有する化合物を含み、
前記アミン化合物(B)が、アルカノールアミン及びアミノ酸より選択される1種以上を含み、
前記カルボン酸化合物(C)が、炭素数3~15の脂肪酸、又はケイ皮酸類を含み、
前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成し
ている、組成物。 Contains a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C),
the photosensitizer (A) contains a compound having a skeleton selected from isoalloxazine and alloxazine,
the amine compound (B) contains one or more selected from alkanolamines and amino acids,
the carboxylic acid compound (C) contains a fatty acid having 3 to 15 carbon atoms or a cinnamic acid,
A composition in which the amine compound (B) and the carboxylic acid compound (C) at least partially form a salt.
前記光増感剤(A)が、イソアロキサジン及びアロキサジンより選択される骨格を有する化合物を含み、
前記アミン化合物(B)が、アミノ基のα水素を有する、アルカノールアミン及びアミノ酸より選択される1種以上を含み、
前記カルボン酸化合物(C)が、脂肪酸を含み、
前記アミン化合物(B)と前記カルボン酸化合物(C)の少なくとも一部が塩を形成しており、
光照射により、前記カルボン酸化合物(C)を徐放する、徐放性組成物。 Contains a photosensitizer (A), an amine compound (B), and a carboxylic acid compound (C),
the photosensitizer (A) contains a compound having a skeleton selected from isoalloxazine and alloxazine,
the amine compound (B) contains one or more selected from alkanolamines and amino acids having an α hydrogen atom of an amino group,
The carboxylic acid compound (C) contains a fatty acid,
the amine compound (B) and the carboxylic acid compound (C) at least partially form a salt;
A sustained release composition which sustains the release of the carboxylic acid compound (C) by irradiation with light.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023056031A JP7497484B1 (en) | 2023-03-30 | 2023-03-30 | Composition |
PCT/JP2024/012029 WO2024204242A1 (en) | 2023-03-30 | 2024-03-26 | Composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023056031A JP7497484B1 (en) | 2023-03-30 | 2023-03-30 | Composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP7497484B1 true JP7497484B1 (en) | 2024-06-10 |
JP2024143384A JP2024143384A (en) | 2024-10-11 |
Family
ID=91377685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023056031A Active JP7497484B1 (en) | 2023-03-30 | 2023-03-30 | Composition |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7497484B1 (en) |
WO (1) | WO2024204242A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021080321A (en) | 2019-11-14 | 2021-05-27 | ユシロ化学工業株式会社 | Water-soluble functional fluid, stock solution of water-soluble functional fluid, water-soluble functional fluid sterilization device, and method for sterilization of water-soluble functional fluid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023052711A (en) * | 2020-03-04 | 2023-04-12 | 国立研究開発法人理化学研究所 | Method for releasing compound |
-
2023
- 2023-03-30 JP JP2023056031A patent/JP7497484B1/en active Active
-
2024
- 2024-03-26 WO PCT/JP2024/012029 patent/WO2024204242A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021080321A (en) | 2019-11-14 | 2021-05-27 | ユシロ化学工業株式会社 | Water-soluble functional fluid, stock solution of water-soluble functional fluid, water-soluble functional fluid sterilization device, and method for sterilization of water-soluble functional fluid |
Also Published As
Publication number | Publication date |
---|---|
JP2024143384A (en) | 2024-10-11 |
WO2024204242A1 (en) | 2024-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9315676B2 (en) | Green approach in metal nanoparticle-embedded antimicrobial coatings from vegetable oils and oil-based materials | |
CN113491709B (en) | Multifunctional high-efficiency compound disinfectant and preparation method thereof | |
CN106719630A (en) | Optical Response controlled release nanometer pesticidal preparations and its preparation method and application | |
CN112831864B (en) | Perilla aldehyde nanofiber and preparation method and application thereof | |
WO2021189987A1 (en) | Pesticide adjuvant and application thereof | |
CN111620964A (en) | Compound essential oil microcapsule preparation for preventing and treating banana wilt and preparation method thereof | |
KR20070095321A (en) | Personal care compositions | |
CN110813012A (en) | Air purifying agent and preparation method and application thereof | |
CN104754944A (en) | Silicon-containing compound aqueous solution and antibacterial/antiviral agent including said solution | |
FI20185450A1 (en) | An antimicrobial composition | |
JP7497484B1 (en) | Composition | |
EA018635B1 (en) | Pesticide compositions, method of making the same and method of controlling agricultural pests | |
Li et al. | Preparation of biological sustained-release nanocapsules and explore on algae-killing properties | |
CN112535181B (en) | Chrysanthemum essential oil microcapsule and preparation method and application thereof | |
RU2315626C1 (en) | Disinfecting detergent (variants) | |
CN109771612A (en) | A kind of preparation method of antibacterial face mask cream | |
DE10101336A1 (en) | Gels for the targeted release of fragrances | |
US11998517B2 (en) | Antimicrobial composition | |
CN113679050B (en) | Fat-soluble tea polyphenol copper assembled nanoflower controlled release carrier and preparation method thereof | |
CN108309899A (en) | A kind of hand wash for children and preparation method thereof | |
Wang et al. | Preparation of Lignin Microcapsules via Interfacial Crosslinking using Deep Eutectic Solution to Dissolve Lignin | |
CN114392378A (en) | Plant component deodorant and preparation method thereof | |
JP2000288076A (en) | Aromatic deodorant composition | |
JP2023025385A (en) | Photocatalyst composition, photocatalyst composition solution, photocatalyst member, and space-disinfecting method | |
CN1256025C (en) | Yin-guo microcapsule suspension emulsion, and its prepn. method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231114 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20231114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240221 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240528 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240529 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7497484 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |